|
US5744593A
(en)
*
|
1996-02-15 |
1998-04-28 |
Heska Corporation |
Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules
|
|
US6369106B1
(en)
*
|
1996-12-26 |
2002-04-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Treatment of ischemic brain injuries with brain targeted anti oxidant compounds
|
|
US6896899B2
(en)
*
|
1996-12-31 |
2005-05-24 |
Antioxidant Pharmaceuticals Corp. |
Pharmaceutical preparations of glutathione and methods of administration thereof
|
|
WO1999026657A1
(en)
*
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
|
US20080275104A1
(en)
*
|
1997-11-25 |
2008-11-06 |
Musc Foundation For Research Development |
Methods of treating juvenile type 1 diabetes mellitus
|
|
US20040072138A1
(en)
*
|
1997-11-25 |
2004-04-15 |
Medical University Of South Carolina |
Attenuation of ischemia/reperfusion injury
|
|
CA2317603A1
(en)
*
|
1998-01-06 |
1999-07-15 |
Cerus Corporation |
Methods for quenching pathogen inactivators in biological materials
|
|
RU2144374C1
(ru)
*
|
1998-11-23 |
2000-01-20 |
Закрытое акционерное общество "ВАМ" |
Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
|
|
US6312734B1
(en)
*
|
1998-11-23 |
2001-11-06 |
Novelos Therapeutics, Inc. |
Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
|
|
US20070142267A1
(en)
*
|
1998-11-23 |
2007-06-21 |
Novelos Therapeutics, Inc. |
Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
|
|
GB2367489B
(en)
*
|
2000-07-31 |
2005-02-09 |
Mars Inc |
Use of antioxidants
|
|
WO2001012166A2
(en)
*
|
1999-08-17 |
2001-02-22 |
University Of Saskatchewan Technologies Inc. |
Improved treatment for acute physical insult to the central nervous system
|
|
US6642274B1
(en)
|
1999-09-09 |
2003-11-04 |
Gary W. Neal |
Methods and compositions for preventing and treating prostate disorders
|
|
EP1214038A2
(en)
*
|
1999-09-09 |
2002-06-19 |
Androsolutions, Inc. |
Methods and compositions for preventing and treating prostate disorders
|
|
PT1086695E
(pt)
*
|
1999-09-21 |
2005-05-31 |
Enzo Leone |
Composicoes antivirais que compreendem ioimbina como principio activo
|
|
WO2001068069A2
(en)
*
|
2000-03-15 |
2001-09-20 |
King's College London |
Pharmaceutical composition comprising paracetamol
|
|
AU2001247762A1
(en)
*
|
2000-03-28 |
2001-10-08 |
Delorenzo, Robert, J |
Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death
|
|
GB0008689D0
(en)
*
|
2000-04-07 |
2000-05-31 |
Nokia Networks Oy |
A method and system for processing signals
|
|
EP1292309A4
(en)
*
|
2000-04-07 |
2004-08-11 |
Sang Geon Kim |
PROPHYLACTIC AND THERAPEUTIC USE OF OLTIPRAZ AS AN AGENT AGAINST FIBROSIS AND CIRRUSH OF THE LIVER AND PHARMACEUTICAL COMPOSITION CONTAINING OLTIPRAZ
|
|
CA2408399A1
(en)
*
|
2000-05-09 |
2001-11-15 |
Nitromed, Inc. |
Infrared thermography and methods of use
|
|
US6528520B2
(en)
*
|
2000-08-15 |
2003-03-04 |
Cpd, Llc |
Method of treating the syndrome of coronary heart disease risk factors in humans
|
|
US6846831B2
(en)
|
2000-08-15 |
2005-01-25 |
Cpd, Llc |
Method of treating the syndrome of lipodystrophy
|
|
WO2002026223A2
(en)
*
|
2000-09-29 |
2002-04-04 |
Board Of Trustees Operating Michigan State University |
Catecholamine pharmaceutical compositions and methods
|
|
US7179791B2
(en)
*
|
2001-01-11 |
2007-02-20 |
Duke University |
Inhibiting GS-FDH to modulate NO bioactivity
|
|
US20020169112A1
(en)
*
|
2001-05-08 |
2002-11-14 |
Luc Montagnier |
Combined treatments and methods for treatment of mycoplasma and mycoplasma-like organism infections
|
|
US20030096770A1
(en)
*
|
2001-07-11 |
2003-05-22 |
Krotz Achim H. |
Enhancement of the stability of oligonucleotides comprising phosphorothioate linkages by addition of water-soluble antioxidants
|
|
WO2003025831A2
(en)
*
|
2001-09-14 |
2003-03-27 |
Roke Manor Research Limited |
Tag and tagging system
|
|
US6726809B2
(en)
*
|
2001-09-26 |
2004-04-27 |
Albany International Corp. |
Industrial process fabric
|
|
US20030119814A1
(en)
*
|
2001-10-16 |
2003-06-26 |
The University Of Kansas |
Novel prodrugs of N-H bond-containing compounds and methods of making thereof
|
|
US20040241256A1
(en)
*
|
2002-12-05 |
2004-12-02 |
Seymour Ehrenpreis |
Medicinal compositions & therapeutic methods
|
|
AU2002357311A1
(en)
*
|
2001-12-18 |
2003-06-30 |
Johns Hopkins University School Of Medicine |
Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes
|
|
US20030194453A1
(en)
*
|
2002-04-15 |
2003-10-16 |
Coleman Henry D. |
Dietary supplement
|
|
US20060099239A1
(en)
*
|
2002-04-15 |
2006-05-11 |
Coleman Henry D |
Dietary supplement for promoting removal of heavy metals from the body
|
|
US20040213829A1
(en)
*
|
2002-04-15 |
2004-10-28 |
Coleman Henry D. |
Dietary supplement
|
|
US20090011048A1
(en)
*
|
2002-04-16 |
2009-01-08 |
Coleman Henry D |
Dietary Supplement For Promoting Removal Of Heavy Metals From The Body
|
|
US20050255129A1
(en)
*
|
2002-05-03 |
2005-11-17 |
Luc Montagnier |
Treatments and methods for treatment, diagnosis and prophylaxis
|
|
US20070065497A1
(en)
*
|
2005-09-20 |
2007-03-22 |
Guilford Frederick T |
Combination and method using EDTA combined with glutathione in the reduced state encapsulated in a liposome to facilitate the method of delivery of the combination as an oral, topical, intraoral or transmucosal, for anti-thrombin effect and for anti-platelet aggregation and measurement of efficacy
|
|
US20100316700A1
(en)
*
|
2002-11-07 |
2010-12-16 |
Guilford F Timothy |
Systemic administration of liposomal reduced glutathione for the decorporation of radioactive materials and non-radioactive mercury
|
|
WO2004055165A2
(en)
*
|
2002-12-13 |
2004-07-01 |
St. Jude Children's Research Hospital |
Glutathione-s-transferase test for susceptibility to parkinson's
|
|
DE10300222A1
(de)
*
|
2003-01-03 |
2004-07-15 |
MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH |
Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen
|
|
US20040229815A1
(en)
*
|
2003-01-03 |
2004-11-18 |
Nagasawa Herbert T. |
Methods for reducing oxidative stress in a cell with a sulfhydryl protected glutathione prodrug
|
|
US8283435B2
(en)
|
2003-02-21 |
2012-10-09 |
Metabolix, Inc. |
PHA adhesive compositions
|
|
JP4724111B2
(ja)
*
|
2003-02-21 |
2011-07-13 |
メタボリックス インコーポレイティッド |
Ｐｈａブレンド
|
|
US8076060B2
(en)
*
|
2003-08-04 |
2011-12-13 |
Emil William Chynn |
Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
|
|
JP2005104852A
(ja)
*
|
2003-09-29 |
2005-04-21 |
Kyowa Hakko Kogyo Co Ltd |
モービリウィルス感染症の予防または治療用組成物
|
|
US20070276024A1
(en)
*
|
2003-10-09 |
2007-11-29 |
Inverseon , Inc. |
Methods for Treating Diseases and Conditions with Inverse Agonists and for Screening for Agents Acting as Inverse Agonists
|
|
US20050250694A1
(en)
*
|
2003-10-10 |
2005-11-10 |
Ma Jian-Xing |
Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
|
|
US20050143300A1
(en)
*
|
2003-10-10 |
2005-06-30 |
Ma Jian-Xing |
Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
|
|
CN102302781A
(zh)
*
|
2003-10-15 |
2012-01-04 |
前体生物药物股份公司 |
谷氨酰胺酰基环化酶效应物和谷氨酸环化酶效应物的应用
|
|
US20050130897A1
(en)
*
|
2003-12-11 |
2005-06-16 |
Ma Jian-Xing |
Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
|
|
JP2007516294A
(ja)
*
|
2003-12-23 |
2007-06-21 |
エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント |
炎症性の疾患または症状の予防および治療のための方法および組成物
|
|
CA2550009C
(en)
*
|
2003-12-30 |
2013-05-14 |
Metabolix, Inc. |
Nucleating agents
|
|
US20050202521A1
(en)
*
|
2004-03-10 |
2005-09-15 |
Albert Crum |
Methods of assessing the need for and the effectiveness of therapy with antioxidants
|
|
WO2005115173A1
(en)
*
|
2004-05-24 |
2005-12-08 |
Ott David M |
Medicinal products incorporating bound organosulfur groups
|
|
JP5066448B2
(ja)
|
2004-09-03 |
2012-11-07 |
協和発酵バイオ株式会社 |
口内炎の予防または治療のための組成物および方法
|
|
US20060083724A1
(en)
*
|
2004-10-01 |
2006-04-20 |
Hilst Todd W |
Compositions for the treatment of femal sexual dysfunction
|
|
PL1817006T3
(pl)
*
|
2004-11-07 |
2013-03-29 |
F Timothy Guilford |
Liposomalny preparat do doustnego podawania glutationu (zredukowanego)
|
|
CN101084003A
(zh)
*
|
2004-12-21 |
2007-12-05 |
重症救护联络公司 |
治疗性营养组合物或联合药物及其使用方法
|
|
CN101150956B
(zh)
*
|
2005-01-27 |
2013-04-17 |
埃里莫斯医药品有限公司 |
用于注射入动物的包括ndga化合物的儿茶酚丁烷配方
|
|
WO2006081363A2
(en)
*
|
2005-01-27 |
2006-08-03 |
Erimos Pharmaceuticals Llc |
Oral formulations for delivery of catecholic butanes including ndga compounds
|
|
US8232240B2
(en)
*
|
2005-02-23 |
2012-07-31 |
The Brigham And Women's Hospital, Inc. |
Inhibitors of enveloped virus infectivity
|
|
EP1888510A4
(en)
|
2005-05-27 |
2013-01-16 |
Univ North Carolina |
NITROGEN OXIDE-RELATED PARTICLES FOR NITROGEN OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS
|
|
US20070004639A1
(en)
*
|
2005-07-01 |
2007-01-04 |
Bodybio, Inc. |
Methods and compositions for treating Parkinson's disease
|
|
EP1906930A2
(en)
*
|
2005-07-13 |
2008-04-09 |
Al Czap |
Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof
|
|
US20110112032A1
(en)
*
|
2005-09-12 |
2011-05-12 |
Ming-He Huang |
Regulation of Brain Natriuretic Peptide and Catecholamines for the Treatment of Cardiovascular Diseases
|
|
GB2430364A
(en)
*
|
2005-09-22 |
2007-03-28 |
Carl Ernest Alexander |
Soft agar bolus for oral drug delivery
|
|
US8093207B2
(en)
*
|
2005-12-09 |
2012-01-10 |
Unigene Laboratories, Inc. |
Fast-acting oral peptide pharmaceutical products
|
|
EA010926B1
(ru)
*
|
2006-01-20 |
2008-12-30 |
Леонид Андреевич Кожемякин |
Средство для лечения туберкулеза глаз, способ его получения и применения
|
|
US20090047340A1
(en)
*
|
2006-03-29 |
2009-02-19 |
Guilford F Timothy |
Liposomal reduced glutathione and 1-arginine, including with other ingredient(s), capable of multipath administration for reversal and prevention of obesity and for mitochondrial biogenesis
|
|
JP5303465B2
(ja)
|
2006-10-05 |
2013-10-02 |
イカリア， インコーポレイテッド |
液体カルコゲナイド組成物ならびにそれを製造および使用する方法
|
|
US20080227846A1
(en)
*
|
2007-03-13 |
2008-09-18 |
Musc Foundation For Research Development |
Methods of treating juvenile type 1 diabetes mellitus
|
|
US20080287341A1
(en)
*
|
2007-05-18 |
2008-11-20 |
Danyang Chen |
Treatment of vascular abnormalities using nanoparticles
|
|
EP2170356A1
(en)
|
2007-06-25 |
2010-04-07 |
Fred Hutchinson Cancer Research Center |
Methods and compositions regarding polychalcogenide compositions
|
|
GB0722923D0
(en)
*
|
2007-11-22 |
2008-01-02 |
Uhi Millennium Inst |
Improved anti-platelet compositions
|
|
JP5406049B2
(ja)
*
|
2008-02-05 |
2014-02-05 |
協和発酵バイオ株式会社 |
グルタチオンの保存安定性向上方法
|
|
JP5499714B2
(ja)
*
|
2008-02-15 |
2014-05-21 |
味の素株式会社 |
腸管免疫賦活剤
|
|
WO2010044875A2
(en)
*
|
2008-10-16 |
2010-04-22 |
Novan, Inc. |
Nitric oxide releasing particles for oral care applications
|
|
JP5208028B2
(ja)
*
|
2009-03-16 |
2013-06-12 |
学校法人帝京大学 |
Ｅｄ評価方法
|
|
US8313456B2
(en)
*
|
2009-06-30 |
2012-11-20 |
Palo Alto Research Center Incorporated |
Drug-transfer device, drug-delivery system incorporating the same, methods of fabricating the same, and methods of enabling administration of a drug
|
|
CA3062005C
(en)
|
2009-08-21 |
2022-02-15 |
Novan, Inc. |
Topical gels comprising nitric oxide-releasing polysiloxane macromolecules and uses thereof
|
|
BR112012003804B1
(pt)
|
2009-08-21 |
2019-02-19 |
Novan, Inc. |
Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
|
|
US20110064828A1
(en)
*
|
2009-09-11 |
2011-03-17 |
Novelos Therapeutics, Incorporated |
Treatment of metastatic tumors and other conditions
|
|
US20110086234A1
(en)
*
|
2009-10-13 |
2011-04-14 |
Nathan Stasko |
Nitric oxide-releasing coatings
|
|
WO2011091807A1
(en)
*
|
2010-01-31 |
2011-08-04 |
Abdelrahman Shata Mohammed Shata |
Anticoagulant and glutathione for treatment of cancer
|
|
US8591876B2
(en)
|
2010-12-15 |
2013-11-26 |
Novan, Inc. |
Methods of decreasing sebum production in the skin
|
|
EP2681286B1
(en)
|
2011-02-28 |
2018-08-15 |
Novan, Inc. |
Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
|
|
AU2013219258B2
(en)
*
|
2012-02-15 |
2017-05-25 |
Kyowa Hakko Bio Co., Ltd. |
Agent for preventing or ameliorating vascular endothelial malfunction
|
|
US20130323324A1
(en)
*
|
2012-06-01 |
2013-12-05 |
Franco Cavaleri |
Vanadium and vanadyl amino acid complexes
|
|
US20140179615A1
(en)
*
|
2012-07-12 |
2014-06-26 |
Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd. |
Glutathione and Acetaminophen Composition and Preparation Method Thereof
|
|
US9475930B2
(en)
|
2012-08-17 |
2016-10-25 |
Metabolix, Inc. |
Biobased rubber modifiers for polymer blends
|
|
JP6469568B2
(ja)
*
|
2012-09-28 |
2019-02-13 |
協和発酵バイオ株式会社 |
グルタチオンを含有する免疫増強剤
|
|
US20140100283A1
(en)
*
|
2012-10-05 |
2014-04-10 |
Atlantic Pro Nutrients, Inc. dba XYMOGEN |
Method to Increase Absorption and Bioavailability of Oral Glutathione
|
|
ES2940822T3
(es)
|
2013-01-21 |
2023-05-11 |
Kyowa Hakko Bio Co Ltd |
Agente elevador de la concentración de óxido nítrico
|
|
WO2014194220A1
(en)
|
2013-05-30 |
2014-12-04 |
Metabolix, Inc. |
Recyclate blends
|
|
IL294448A
(en)
|
2013-12-24 |
2022-09-01 |
Univ Virginia Commonwealth |
Uses of oxidized cholesterol sulfates
|
|
PT3104939T
(pt)
|
2014-02-10 |
2024-07-17 |
Fred Hutchinson Cancer Center |
Tratamento de ataque cardíaco e lesão isquémica com iodeto de sódio
|
|
CA2961380A1
(en)
*
|
2014-09-15 |
2016-03-24 |
Sound Pharmaceuticals Incorporated |
Methods and compositions for treating psychotic disorders
|
|
CA3081693C
(en)
*
|
2014-10-09 |
2022-01-11 |
Albert Crum |
Protective metallothionein analog compounds, their compositions and use thereof in the reduction of heavy metal toxicity
|
|
US20160367620A1
(en)
*
|
2015-06-19 |
2016-12-22 |
Harry B. Demopoulos |
Glutathione
|
|
WO2017091737A1
(en)
*
|
2015-11-25 |
2017-06-01 |
Molecular Defenses Corporation |
Pharmaceutical formulations
|
|
US10702590B2
(en)
*
|
2016-04-12 |
2020-07-07 |
Script Essentials, Llc |
Compositions and methods for treating thyroid disease
|
|
US20180008665A1
(en)
*
|
2016-07-05 |
2018-01-11 |
CanTrust LifeScience Corp. |
Methods of treating and preventing gout and lead nephropathy
|
|
US11602555B2
(en)
|
2016-11-17 |
2023-03-14 |
Renovion, Inc. |
Treatment of respiratory tract diseases and infections with ascorbic acid compositions
|
|
ES3008699T3
(en)
|
2017-11-17 |
2025-03-24 |
Renovion Inc |
Stable ascorbic acid compositions and methods of using the same
|
|
US11344497B1
(en)
|
2017-12-08 |
2022-05-31 |
Quicksilver Scientific, Inc. |
Mitochondrial performance enhancement nanoemulsion
|
|
US10722465B1
(en)
|
2017-12-08 |
2020-07-28 |
Quicksilber Scientific, Inc. |
Transparent colloidal vitamin supplement
|
|
US11291702B1
(en)
|
2019-04-15 |
2022-04-05 |
Quicksilver Scientific, Inc. |
Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method
|
|
EP3733197A1
(en)
*
|
2019-04-30 |
2020-11-04 |
Stephen N. Pitcher |
Anaerobic antioxidant composition
|
|
JP2022074429A
(ja)
*
|
2020-11-04 |
2022-05-18 |
三菱商事ライフサイエンス株式会社 |
グルタチオン機能促進剤及びその方法
|
|
EP4289444A1
(en)
*
|
2021-02-02 |
2023-12-13 |
Nesa LLC |
Anti-viral agent
|
|
KR20240131358A
(ko)
|
2022-01-04 |
2024-08-30 |
레노비온, 아이엔씨. |
글루타치온 염을 포함하는 수용액
|
|
IT202200007229A1
(it)
*
|
2022-04-12 |
2023-10-12 |
Uriach Italy S R L |
Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
|
|
IT202200007232A1
(it)
*
|
2022-04-12 |
2023-10-12 |
Uriach Italy S R L |
Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
|
|
WO2023199241A1
(en)
*
|
2022-04-12 |
2023-10-19 |
URIACH ITALY S.r.l. |
Composition comprising lipoic acid, vitamin d and glutathione, uses thereof, and pharmaceutical and nutraceutical compositions thereof
|
|
IT202200007238A1
(it)
*
|
2022-04-12 |
2023-10-12 |
Uriach Italy S R L |
Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
|
|
PE20251171A1
(es)
*
|
2022-04-12 |
2025-04-23 |
Uriach Italy S R L |
Composicion que comprende n-acetilcisteina, vitamina d y preferentemente glutation, usos de la misma y composiciones farmaceuticas y nutraceuticas de la misma
|
|
KR102602347B1
(ko)
*
|
2022-05-09 |
2023-11-15 |
천현수 |
위장내 발암성 엔-니트로사민 생성 억제 및 장내 산화질소 생성 촉진용 천연 조성물 및 이의 용도
|